Article Information
History
- May 8, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Qihong Yan1,5,†,
- Pingchao Li1,†,
- Xianmiao Ye1,†,
- Xiaohan Huang1,5,†,
- Xiaoneng Mo2,
- Qian Wang1,
- Yudi Zhang1,
- Kun Luo1,
- Zhaoming Chen1,
- Jia Luo1,
- Xuefeng Niu3,
- Ying Feng3,
- Tianxing Ji3,
- Bo Feng3,
- Jinlin Wang2,
- Feng Li2,
- Fuchun Zhang2,
- Fang Li2,
- Jianhua Wang1,
- Liqiang Feng1,
- Zhilong Chen4,*,
- Chunliang Lei2,*,
- Linbing Qu1,* and
- Ling Chen1,2,3,4,*
- 1Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
- 2Guangzhou Institute of Infectious Disease, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China
- 3State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
- 4School of Medicine, Huaqiao University, Xiamen, China
- 5University of Chinese Academy of Science, Beijing, China
- ↵*To whom correspondence should be addressed: Ling Chen (chen_ling{at}gibh.ac.cn), Linbing Qu (qu_linbing{at}gibh.ac.cn), Chunliang Lei (gz8hlcl{at}163.com), Zhilong Chen (aloongchan{at}163.com)
↵† These authors contributed equally to this work.
Posted May 08, 2020.
Longitudinal peripheral blood transcriptional analysis of COVID-19 patients captures disease progression and reveals potential biomarkers
